You are here
Personal development is a key success factor o any company. At ABL, we promote individuals, encourage their initiatives and create a convenient environment to let the best skills be expressed, with a permanent focus on the team's collective objectives..
Marc brings more than 20 years of experience as a scientist and a senior executive in the biotechnology industry.
Prior to joining ABL, Marc was the COO of ENDODIAG in Paris, France, VP of Marketing & Sales for IPSOGEN in Marseille, and the Director of Business Development at ELSEVIER in Paris.
Throughout his career, Marc successfully developed and launched several molecular diagnostic tests in oncology, managed a network of 50 distributors worldwide, oversaw a successful IPO, and managed the first endometriosis observatory, an e-health project gathering endometriosis patients, physicians, and scientists. He holds a PhD in Molecular Biophysics from the University of Paris 6 and a Master in Strategic Marketing.
Director of Operations
Cendrine joined ABL in 2013 with more than 16 years of industry experience in immunotechnology and management of scientific projects ranging from assay development to assay validation for biotechnologies, pharmaceutical and cosmetic industries.
Prior to joining ABL, Cendrine gained 13 years of experience as Platform manager for Indicia Biotechnology in Lyon, France. She was notably in charge of the evaluation and implementation of cutting edge technologies such as Luminex®, Erenna® (Singulex) and SIMOA® (Quanterix) Immunoassay technologies.
Cendrine completed a Master Degree in Immunotechnology from the University of Luminy (Aix Marseille).
Christine brings more than 23 years of experience in immunology and coordination of immunomonitoring studies in the context of clinical trials in oncology and infectious diseases. She is now in charge of scientific affairs from development of internal R&D program to implementation of external collaborative projects with our partners.
Prior to joining ABL, Christine conducted research program in the team of Genevieve Inchauspe, focusing on immuno-pathogenesis of Hepatitis C virus, and coordinated immunomonitoring of Transgene’s clinical studies. Christine holds a PhD of Immunology from the University of Lyon.
Isabelle has more than 20 years of experience in Quality Assurance in the pharmaceutical industry. She participated to the inception of ABL by setting up and supporting quality management system which led to the ISO 9001:2008 certification in compliance with GLP guidelines.
Throughout her career, she worked 10 years at Johnson & Johnson consumer as European Quality Assurance Manager on cosmetics, medical devices and drug products. She was mainly in charge of supporting R&D people through technology transfer activities from R&D to plant and contractors, but also R&D Quality process, electronic documentation system development and implementation at local, regional and worldwide level. Isabelle was also Pilot area manager in charge of scale-up, clinical and stability production batches.
Isabelle holds a master degree in chemistry of the University of Science in Nice –Sophia Antipolis and made specialization in pharmaceutical industry at the University of pharmacy Lyon Claude Bernard (IPIL).